norethindrone acetate has been researched along with Fibrocystic Breast Disease in 1 studies
norethisterone acetate : A 3-oxo Delta(4)-steroid that is norethisterone in which the hydroxy group has been converted to its acetate ester.
Fibrocystic Breast Disease: A common and benign breast disease characterized by varying degree of fibrocystic changes in the breast tissue. There are three major patterns of morphological changes, including FIBROSIS, formation of CYSTS, and proliferation of glandular tissue (adenosis). The fibrocystic breast has a dense irregular, lumpy, bumpy consistency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mossa, B | 1 |
| Pelle, R | 1 |
| Tocci, B | 1 |
| Florio, V | 1 |
1 other study available for norethindrone acetate and Fibrocystic Breast Disease
| Article | Year |
|---|---|
[Treatment with danazol of breast adenosis. A comparative note].
Topics: Adolescent; Adult; Danazol; Female; Fibrocystic Breast Disease; Humans; Middle Aged; Norethindrone; | 1989 |